UK Pharma Industry Bracing for Possible Disruption

From FierceBiotech: GlaxoSmithKline CEO Andrew Witty fears that if the European Medicines Agency (EMA) is moved from London, it will cause a tremendous disruption for the UK’s pharma and biotech industry. Experts worry about the possibility of regulatory upheaval if Brexit happens. The fate of the EMA is in the air. Brexit is currently in[…]

Cannabis Extracts Classified as Medicine in the UK

Across the pond, Cannabidiol (CBD) is set to be classified as a medicine within the UK. This comes after a decision by the Medicines & Healthcare products Regulatory Agency (MHRA) after reviewing claims of CBD successfully treating serious diseases. This means that products containing CBD can be legally distributed and purchased across the UK. CBD[…]